Cambrex - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Cambrex M&A Summary

Cambrex has acquired 7 companies of its own, including 2 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 1 asset.

Cambrex’s largest acquisition to date was in 2018, when it acquired Cambrex Drug Product- Business Unit for $425M. Cambrex has acquired in 4 different US states, and 4 countries. The Company’s most targeted sectors include life science (72%) and chemicals (15%).

Cambrex Ownership

Who owns Cambrex?

Cambrex is owned by Permira. It was acquired on August 7, 2019.

Is Cambrex PE-backed?

Yes. Cambrex is owned by private equity investor Permira.

Cambrex Business Overview

Where is Cambrex headquartered?

Cambrex is headquartered in East Rutherford, New Jersey.

What is Cambrex’s revenue?

Cambrex disclosed revenue of 534M USD for 2017 and 491M USD for 2016.

How many employees does Cambrex have?

Cambrex has 1,228 employees.

What sector is Cambrex in?

Cambrex is a life science company.

When was Cambrex founded?

Cambrex was founded in 1981.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity7
    • M&A Sell Activity1
  • Total Sectors Invested 3
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 4
  • M&A Advisors 1

Cambrex

Cambrex Corp.

One Meadowlands Plaza,
East Rutherford, New Jersey 07073
United States,
(201) 804-3000
www.cambrex.com

Cambrex is a life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapeutics. Cambrex was formed in 1981 and is headquartered in East Rutherford, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # 5 - - 2 - - 7
vol $702M $702M
Sell (0.2/yr) # - - - - 1 - 1
  8

Most Recent M&A

Company Date Value Type
Cambrex Drug Product- Business Unit 2023-11-02 - Divestiture
Whippany, New Jersey
Snapdragon Chemistry, Inc. 2022-11-21 - Add-on Acquisition
Waltham, Massachusetts · www.snapdragonchemistry.com
Q1 Scientific 2022-06-01 - Add-on Acquisition
Waterford, Ireland · www.q1scientific.com
Avista Pharma Solutions 2018-11-20 252M USD Add-on Acquisition
Lafayette, Colorado · www.avistapharma.com
Cambrex Drug Product- Business Unit 2018-07-23 425M USD Add-on Acquisition
Whippany, New Jersey
PharmaCore, Inc. 2016-09-26 25M USD Add-on Acquisition
High Point, North Carolina · www.pharmacore.com
Zenara Pharma 2010-11-02 - Stake Purchase
Hyderabad, India
IEP GmbH 2010-03-22 - Add-on Acquisition
Wiesbaden, Germany · www.biocatalysis.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (71%) 277M (39%) - -
Healthcare Services 1 (14%) 425M (61%) 1 (100%) -
Chemicals 1 (14%) - - -
Total 7 $702M 1 -

By Geo

State/Country Buy Value Sell Value
United States 4 702M 1 -
  New Jersey 1 425M 1 -
  North Carolina 1 25M - -
  Massachusetts 1 - - -
  Colorado 1 252M - -
Germany 1 - - -
India 1 - - -
Ireland 1 - - -
Domestic 4 (57%) 702M (100%) 1 (100%) -
Cross-border 3 (43%) - - -
Total 7 $702M 1 -

Top M&A Advisors

Legal Deals
Ropes & Gray
2

Deal Values

buy # Total
$100M to $1B 2 $677M
< $100M 1 $25M
TOTAL $702M
Largest Cambrex Drug Product- Business Unit
$425M (2018-07-23)

M&A Connections

Deals
Acquired from
Investor(s)
43%
3 (43%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.